SenoRx, Inc. (NASDAQ:SENO)

CAPS Rating: No stars

The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.

Recs

0
Player Avatar jhe2jhe (37.99) Submitted: 9/27/2007 7:01:37 PM : Outperform Start Price: $8.38 SENO Score: -10.41

Great startup will do well. Very good business lan in a much needed area with outstanding products

Featured Broker Partners


Advertisement